Author:
Briggs Daniel,Telford Luke,Lloyd Anthony,Ellis Anthony
Publisher
Springer International Publishing
Reference133 articles.
1. Altindis, E. (2022). Inequitable COVID-19 vaccine distribution and the intellectual property rights prolong the pandemic. Expert Review of Vaccines, 21(4), 427–430.
2. Amgen. (n.d.). About Amgen. Amgen. Accessed on 25/04/2023. https://www.amgen.com/about
3. Andrews, N., Stowe, J., Ramsay, M., & Miller, E. (2022). Risk of venous thrombotic events and thrombocytopenia in sequential time periods after ChAdOx1 and BNT162b2 COVID-19 vaccines: A national cohort study in England. The Lancet Regional Health, 13, 1–10.
4. Arguedas-Ramírez, G. (2022). A call to action against persistent lack of transparency in vaccine pricing practices during the COVID-19 pandemic. Annals of Global Health, 88(1), 1–6.
5. Attaran, A., & Gillespie-White, L. (2001). Do patents for antiretroviral drugs constrain access to AIDS treatment in Africa? JAMA Network, 286(15), 1886–1892.